Status:
COMPLETED
The Difference of Grey Matter Volume Among the Patients of Schizophrenia
Lead Sponsor:
Shanghai Mental Health Center
Conditions:
Schizophrenia
Neuroimaging
Eligibility:
All Genders
18-60 years
Brief Summary
Schizophrenia is a heritable complex phenotype whose symptoms can be clustered into three domains: positive symptoms, negative symptoms and cognitive impairments. Constellations of negative symptoms i...
Detailed Description
Schizophrenia (SCZ) is a heritable complex phenotype whose symptoms can be clustered into three domains: positive symptoms, negative symptoms and cognitive impairments. Constellations of negative symp...
Eligibility Criteria
Inclusion
- All the patients satisfied the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-Ⅳ) diagnostic criteria for schizophrenia or schizophreniform disorder.
- Women and men
- 18 to 60 years of age
- Able and willing to provide written informed consent; and willing to commit to the study protocol
- Able to read, speak, and understand Chinese
Exclusion
- (i) were \<18 years or \>60 years
- (ii) psychotic patients in unstable clinical condition (e.g., being aggressive and uncooperative)
- (iii) had major neurological or other psychiatric disorders, or significant medical condition including neurological disease, severe cardiovascular, hepatic, renal diseases
- (iv)had MRI abnormalities, or had MRI contraindications.
Key Trial Info
Start Date :
June 26 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
253 Patients enrolled
Trial Details
Trial ID
NCT05262790
Start Date
June 26 2013
End Date
January 1 2017
Last Update
March 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.